Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 3,006.90
+93.90 (3.22%)
At close: Oct 6, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 519.74 billion as of October 7, 2026. Its market cap has increased by 62.64% in one year.
Market Cap
519.74B
Enterprise Value
488.99B
Revenue
67.25B
Ranking
n/a
PE Ratio
46.04
Stock Price
3,006.90
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 519.74B, an increase of 74.94%. That is a compound annual growth rate of 9.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 519.74B | 83.20% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.81T |
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |